A Day Up For Jasper Therapeutics Inc.

Tue, Jan 03, 2023 at 06:58 PM

Jasper Therapeutics Inc. (JSPR:NASDAQ) rocketted at $2.74, representing a gain of 476.4%. On Tue, Jan 03, 2023, JSPR:NASDAQ hit a New 2-Week High of $2.74. The stock appeared on our News Catalysts scanner on Tue, Jan 03, 2023 at 08:24 AM in the 'BIOTECH' category. From Tue, Dec 20, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days

The stock spiked on Tue, Jan 03, 2023 at $3.8 with a volume of 62M+.

About Jasper Therapeutics Inc. (JSPR:NASDAQ)

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy.

Top 10 Gainers:

Jasper Therapeutics Inc. (JSPR:NASDAQ), 476.36%
Lucira Health Inc. (LHDX:NASDAQ), 440.05%
Horizon Global Corporation (HZN:NYSE), 342.39%
Vivos Therapeutics Inc. (VVOS:NASDAQ), 84.08%
Gelesis Holdings Inc. (GLS:NYSE), 79.06%
Motorsport Games Inc. (MSGM:NASDAQ), 67.47%
180 Life Sciences Corp. (ATNF:NASDAQ), 56.34%
Viveve Medical, Inc. (VIVE:NASDAQ), 54.76%
Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 49.39%
iBio, Inc. (IBIO:NYSEMKT), 48.51%